Paper28701774
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.
Henriques A and 9 others. Sci Rep, 2017. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis. Papers, record 28701774. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28701774
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| Disease Models, Animal | Major topic |
| Glucosylceramidase | Major topic |
| Glycosphingolipids | Major topic |
| Motor Neurons | Major topic |
| Spinal Cord | Major topic |
| Superoxide Dismutase | Major topic |
| Aged | |
| Animals | |
| Case-Control Studies | |
| Female | |
| Humans | |
| Male | |
| Mice | |
| Mice, Knockout | |
| Neuromuscular Junction | |
| PC12 Cells | |
| Rats | |
| Signal Transduction |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8815167 | Neurotrophins increase motoneurons' ability to innervate skeletal muscle fibers in rat spinal cord--human muscle cocultures. | J Neurol Sci | 1996 | https://conductscience.org/library/papers/8815167 | PubMed |
| 2 | 27234572 | Delineating pathological pathways in a chemically induced mouse model of Gaucher disease. | J Pathol | 2016 | https://conductscience.org/library/papers/27234572 | PubMed |
| 3 | 18164265 | Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. | Clin Chim Acta | 2008 | https://conductscience.org/library/papers/18164265 | PubMed |
| 4 | 4037752 | Ganglioside patterns in amyotrophic lateral sclerosis brain regions. | Ann Neurol | 1985 | https://conductscience.org/library/papers/4037752 | PubMed |
| 5 | 96213 | The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects. | J Neurochem | 1978 | https://conductscience.org/library/papers/96213 | PubMed |
| 6 | 21188408 | Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. | J Neurol | 2011 | https://conductscience.org/library/papers/21188408 | PubMed |
| 7 | 16775390 | Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. | Neuromolecular Med | 2006 | https://conductscience.org/library/papers/16775390 | PubMed |
| 8 | 6502751 | Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis. | J Neurosci Res | 1984 | https://conductscience.org/library/papers/6502751 | PubMed |
| 9 | 25618254 | Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. | J Neurol | 2015 | https://conductscience.org/library/papers/25618254 | PubMed |
| 10 | 25316019 | Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? | Lancet Neurol | 2014 | https://conductscience.org/library/papers/25316019 | PubMed |
| 11 | 25869998 | Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD). | Trends Genet | 2015 | https://conductscience.org/library/papers/25869998 | PubMed |
| 12 | 24243840 | The Reactome pathway knowledgebase. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/24243840 | PubMed |
| 13 | 2913936 | Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. | Ann Neurol | 1989 | https://conductscience.org/library/papers/2913936 | PubMed |
| 14 | 26056266 | Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26056266 | PubMed |
| 15 | 18054258 | Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention. | Blood Cells Mol Dis | 2008 | https://conductscience.org/library/papers/18054258 | PubMed |
| 16 | 25820275 | A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. | EMBO Mol Med | 2015 | https://conductscience.org/library/papers/25820275 | PubMed |
| 17 | 26968461 | Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery. | Biochim Biophys Acta | 2016 | https://conductscience.org/library/papers/26968461 | PubMed |
| 18 | 15263088 | Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15263088 | PubMed |
| 19 | 12065629 | GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. | J Neurochem | 2002 | https://conductscience.org/library/papers/12065629 | PubMed |
| 20 | 26024958 | The multi-tasked life of GM1 ganglioside, a true factotum of nature. | Trends Biochem Sci | 2015 | https://conductscience.org/library/papers/26024958 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42259784 | Long-term inhibition of lysosomal glucocerebrosidase activity promotes GPX4 stability and inhibits ferroptosis in dopaminergic neurons. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42259784 | PubMed |
| 41227379 | Does Amyotrophic Lateral Sclerosis (ALS) Have Metabolic Causes from Human Evolution? | Cells | 2025 | https://conductscience.org/library/papers/41227379 | PubMed |
| 39575748 | Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications. | Antioxid Redox Signal | 2024 | https://conductscience.org/library/papers/39575748 | PubMed |
| 38623278 | Gangliosides as Therapeutic Targets for Neurodegenerative Diseases. | J Lipids | 2024 | https://conductscience.org/library/papers/38623278 | PubMed |
| 37885330 | GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons. | FEBS Open Bio | 2023 | https://conductscience.org/library/papers/37885330 | PubMed |
| 37622689 | Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/37622689 | PubMed |
| 37298512 | Ganglioside GM1 and the Central Nervous System. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298512 | PubMed |
| 36836867 | Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36836867 | PubMed |
| 36345044 | Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. | Transl Neurodegener | 2022 | https://conductscience.org/library/papers/36345044 | PubMed |
| 35625841 | Lipid Metabolic Alterations in the ALS-FTD Spectrum of Disorders. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625841 | PubMed |
| 35586217 | Two Liberibacter Proteins Combine to Suppress Critical Innate Immune Defenses in Citrus. | Front Plant Sci | 2022 | https://conductscience.org/library/papers/35586217 | PubMed |
| 35576218 | A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules. | PLoS One | 2022 | https://conductscience.org/library/papers/35576218 | PubMed |
| 34572266 | Storage of Mutant Human SOD1 in Non-Neural Cells from the Type-1 Amyotrophic Lateral Sclerosis ratG93A Model Correlated with the Lysosomes' Dysfunction. | Biomedicines | 2021 | https://conductscience.org/library/papers/34572266 | PubMed |
| 34349634 | The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/34349634 | PubMed |
| 34193885 | Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders. | Sci Rep | 2021 | https://conductscience.org/library/papers/34193885 | PubMed |
| 33602014 | Better understanding the neurobiology of primary lateral sclerosis. | Amyotroph Lateral Scler Frontotemporal Degener | 2020 | https://conductscience.org/library/papers/33602014 | PubMed |
| 33117120 | Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications. | Front Neurosci | 2020 | https://conductscience.org/library/papers/33117120 | PubMed |
| 32528400 | Exploring Sphingolipid Implications in Neurodegeneration. | Front Neurol | 2020 | https://conductscience.org/library/papers/32528400 | PubMed |
| 31447678 | Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31447678 | PubMed |
| 30116051 | Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/30116051 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGRN | 375790 | PubTator's text mining | https://conductscience.org/library/genes/375790 | NCBI Gene |
| ATF3 | 467 | PubTator's text mining | https://conductscience.org/library/genes/467 | NCBI Gene |
| ATF4 | 468 | PubTator's text mining | https://conductscience.org/library/genes/468 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| FUS | 2521 | PubTator's text mining | https://conductscience.org/library/genes/2521 | NCBI Gene |
| GBA1 | 2629 | PubTator's text mining | https://conductscience.org/library/genes/2629 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
| TARDBP | 23435 | PubTator's text mining | https://conductscience.org/library/genes/23435 | NCBI Gene |
| TNFRSF1B | 7133 | PubTator's text mining | https://conductscience.org/library/genes/7133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28701774
GET https://conductscience.org/api/papers/v1/28701774/references?page=2